Clinical trial
Non-invasive Monitoring of Patients At Risk of Acute Compartment Syndrome (ACS) with CPMX1
NCT06030635 is registered in ClinicalTrials.gov with Compremium AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-invasive Monitoring of Patients At Risk of Acute Compartment Syndrome (ACS) with CPMX1
- Lead sponsor
- Compremium AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 25, 2023
- Completion date
- October 22, 2024
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.